Cumberland Pharmaceuticals Inc.
CPIX
$5.72
-$0.14-2.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.29M | -1.41M | -1.94M | -740.70K | 1.26M |
| Total Depreciation and Amortization | 1.56M | 1.33M | 1.32M | 1.32M | 1.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 118.70K | 117.90K | -3.50K | 8.50K | 196.80K |
| Change in Net Operating Assets | 2.00M | -30.30K | 808.40K | 256.90K | 1.13M |
| Cash from Operations | 387.00K | 3.00K | 187.20K | 843.80K | 3.90M |
| Capital Expenditure | -- | 0.00 | -23.80K | -26.50K | -47.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.20K | -3.07M | -667.00K | 312.40K | -1.18M |
| Cash from Investing | -61.20K | -3.07M | -690.80K | 285.90K | -1.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -10.04M |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 5.27M |
| Repurchase of Common Stock | -61.00K | 0.00 | -10.40K | -7.20K | -245.90K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -702.30K | -681.70K | -376.40K | -143.60K | -511.10K |
| Cash from Financing | -763.30K | -681.70K | -386.90K | -150.80K | -5.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -437.40K | -3.75M | -890.50K | 978.90K | -2.86M |